Brown Norway rat asthma model of diphenylmethane-4,4′-diisocyanate (MDI): Impact of vehicle for topical induction
Introduction
When designing an in vivo model of respiratory allergy, it is important to clearly decide which aspects of this complex disease is the focus. In addition to expedience and practicability, the species and strain selection, the sensitization and challenge protocol as well as the endpoint(s) chosen are paramount for the outcome of test. The relative abundance of biomarkers to probe responsiveness may change from one compartment to another and, for example, it may be different in serum, lung parenchyma and draining lymph nodes or bronchoalveolar lavage fluid (BALF) (Schuster et al., 2000, Pauluhn, 2006). However, how these tissue microenvironments shape the function of professional antigen-presenting cells remains elusive. In terms of endpoints, those that integrate independently a series of complex events might be most practical to probe for positive responses in animal models in order to detect and categorize lung-sensitizing agents. Once identified, dose (concentration × time)–response analyses may facilitate risk assessment. Suffice it to say, particularly for dose–response analyses, the inhalation route is considered to be superior to expedient ‘shortcut’ bolus dosing procedures as they may not adequately dose the bronchial airways, the site asthma prevails. Limitations of most of the currently applied bioassays are that they model the acute rather than the chronic manifestation of asthma. Apart from the difficulties in transposing rodent to human data, it has to be borne in mind that each animal model is a trait associated with asthma, rather than for modeling the entire asthma phenotype (Kips et al., 2003, Kumar and Foster, 2002, Redlich et al., 2002).
Allergic asthma is a pulmonary disease characterized by episodes of acute airway inflammation superimposed on a background of chronic inflammation and structural changes collectively referred to as airway wall remodeling and airway hyper-responsiveness to a variety of stimuli (Kumar, 2001, Maddox and Schwartz, 2002). It was sought to develop a Brown Norway (BN) rat model of chronic asthma in which topically sensitized animals were repeatedly challenged by inhalation to a carefully controlled, minimally irritant concentration × time relationship of MDI–aerosol, to minimize the likelihood of eliciting marked parenchymal inflammation. Currently, most rodent models are more correctly designated models of allergic bronchopulmonary inflammation rather than of a bronchial airway-specific inflammation. However, when using this repeated challenge protocol, BN rats exhibited many of the lesions that typify chronic human asthma (Pauluhn et al., 2005, Pauluhn, 2006). The focus of this animal model was to elicit an acute-on-chronic allergic inflammation of the airways and to consider the compartmentalization of pulmonary responses (Schuster et al., 2000).
The majority of current rodent models of asthma include a priming phase, when animals are sensitized by topical administration of the inciting agent. Sometimes this administration is together with a Th2-skewing adjuvant. The exact roles played by Th1 and Th2 cytokines during the initial phase of sensitization in the development of eosinophils-mediated and neutrophil-mediated asthma remain unclear (Fischer et al., 2007, Johnson et al., 2004). Although not typically considered to be a Th2 cytokine, TNF-α is prominent in asthmatic airways, and genotypes that correlate with increased TNF-α secretion are associated with an increased risk of asthma (Moffatt and Cookson, 1997), suggesting that TNF-α plays an important role in the development of asthma and allergic airways inflammation. Because of their unique profile of cytokine production, it was proposed to distinguish ‘inflammatory Th2’ cells (IL-4, IL-5, IL-13, IL-10) from ‘conventional Th2’ cells (IL-4, IL-5, IL-13, TNF-α) (Liu et al., 2007). However, it should be recognized that bronchial asthma is not the only isocyanate-induced disorder. Nonobstructive bronchitis, rhinitis, cutaneous hypersensitivity, and hypersensitivity pneumonitis represent further diagnoses that may be associated with antibody responses (Baur, 2007).
Diisocyanates are widely used in industry and are known to be involved as causative agents for occupational asthma (Chan-Yeung and Malo, 1994). The pathogenesis associated with low-molecular-weight diisocyanates is not well understood and the current literature indicates that pathomechanisms involved in isocyanate-induced disorders are complex and heterogeneous. This includes the role of the dermal route of induction for priming and the inhalation route to elicit an asthma-like disease. More recently, concerns have been raised that skin exposure to isocyanates may prime exposed individuals to the subsequent development of asthma as a result of inhalation exposures (Bello et al., 2007). So far the sequence and frequency of exposure as well as the additional determining factors leading to disease remain poorly defined (Basketter et al., 2006, Boukhman and Maibach, 2001, Pauluhn, 2006). Among the issues contributing to controversy is the lack of knowledge whether the total dose, the concentration of the hapten (allergen), adjuvants (or irritation), absorption enhancers (vehicles) or skin injury, the exposed skin surface area, the frequency or repeated contact with the skin, and subsequent single or recurrent high-level inhalation excursions either alone or in combinations might be the critical determinant(s) leading to disease in susceptible individuals.
It has been recognized for many years that the vehicle matrix in which a chemical allergen (hapten) is encountered on the skin may have profound effects on the response elicited and the extent to which skin sensitization will be acquired (Kligman, 1966, Basketter et al., 2001). Although not all chemical allergens are affected similarly, for certain substances a greater than 10-fold vehicle dependent change in potency is observed (Basketter et al., 2001). In the guinea pig, it has been shown that the vehicle can substantially affect the rate of sensitization, although this could not be related to the apparent bioavailability (Andersen et al., 1985). However, the view that the vehicle matrix is likely to have an important impact on the sensitizing effect of a chemical is also based on the underlying knowledge of skin penetration.
Especially for potentially irritant chemicals, such as MDI, skin damage-associated factors may be released by stressed tissue or necrotic cells which then modulate the functional maturation of antigen presenting cells (Langerhans’ cells) (Lambrecht and van den Toorn, 2007). Thus, selection of the vehicle solvent for delivery of MDI to the skin and the dose metric (total dose or skin surface area concentration) are important determinants of the outcome and deserve better appreciation during study design and execution. Chemical reactivity of MDI with skin proteins, water, sweat components, and self polymerization reactions, as well as limited understanding of the kinetics of these processes on the skin and the role of solvent on skin penetration and bioavailability of MDI, further emphasize the need to pay closer attention to these factors. For these reasons, quantitative assessment of the vehicle effect and dose metric are time-consuming and technically challenging.
The objective of this study was to study the modifying impact on MDI-induced respiratory allergy (asthma) of three modes of topical skin exposure while maintaining an equivalent total dose and surface area. For this purpose groups of rats were topically sensitized to MDI dissolved in the two different vehicles, namely di-n-octyl sebacic acid ester (20%) (SEBA) and acetone:olive oil (20%) (AOO). Similarly dosed rats using undiluted MDI served as reference. The modifying role of these priming procedures on pro-inflammatory cytokines/chemokines and the recruitment of inflammatory cells in various lung compartments in repeatedly MDI–aerosol challenged BN rats were evaluated. SEBA was considered to be a nonreactive, nonvolatile lipophilic vehicle, whilst AOO (4:1) has been suggested as the vehicle of choice for other topical sensitization bioassays (Basketter and Kimber, 1996). Neither vehicle has any relevance to occupational exposure but may alter the stability, duration of topical exposure and thus the potential for skin penetration and bioavailability of this reactive chemical. Accordingly, the modifying properties caused by different formulation matrices were the focus of study.
Section snippets
Test material and chemicals
Polymeric methylenediphenyl-4,4′-diisocyanate (MDI) was from Bayer Material Science AG, Leverkusen, Germany. The content of monomeric MDI isomers was 43.9% (39.3% 4,4′-MDI) with higher oligomeric MDI as balance. The free isocyanate (NCO) content was 31.23%. Di-n-octyl sebacic acid ester (>95%), acetone (Seccosolv, max. 0.01% H2O) and Olive oil were from Tokyo Chemical Industry (TCI) CO., Merck, and Fluka, respectively.
Animals, diet, and housing conditions
Brown Norway (BN) rats of the strain BN/Crl BR were purchased from Charles
Results
Lung weights, BAL-protein, -LDH, -total cell counts, -neutrophilic granulocytes, and -lymphocytes were significantly increased in all groups sensitized to and challenged with MDI (comparison with naïve control; Fig. 2, Fig. 3, Fig. 4). There was a consistent tendency that effects were slightly more pronounced in the group using the SEBA as vehicle.
With regard to the comparative evaluation of selected cytokines and chemokines in bronchoalveolar lavage fluid (BALF), -cells (BALC), and LALNs
Discussion
Previous sensitization studies with MDI in BN rats have demonstrated stereotypical changes in breathing patterns delayed in onset following topical induction to and repeated inhalation challenges with MDI (Pauluhn, 2005, Pauluhn et al., 2005, Pauluhn and Vohr, 2006). Furthermore, those studies demonstrated a progressive increase in the respiratory response with increasing number of inhalation challenge exposures to mildly irritant concentrations of MDI–aerosol. In contrast, repeated inhalation
Acknowledgments
The author thanks P. Eidmann, and A. Thiel for excellent technical assistance, Dres. I. Loof, Ellinger-Ziegelbauer, Prof. H.-W. Vohr for lung lavage analyses, and Dr. A. Folkerts for analytical determinations of MDI.
References (42)
Evidence for allergic reactions in isocyanate asthma
The Journal of Allergy and Clinical Immunology
(2007)- et al.
Skin sensitization, vehicle effects and the local lymph node assay
Food and Chemical Toxicology
(2001) - et al.
Thresholds in contact sensitization: Immunologic mechanisms and experimental evidence in humans – an overview
Food and Chemical Toxicology
(2001) - et al.
Th1 and Th2 cells are required for both eosinophils- and neutrophil-associated inflammatory responses in mice
Biochemical and Biophysical Research Communications
(2007) The identification of contact allergens by human assay. II: Factors influencing the induction and measurement of allergic contact dermatitis
The Journal of Investigative Dermatology
(1966)Understanding airway wall remodeling in asthma: a basis for improvements in therapy?
Pharmacology & Therapeutics
(2001)Respiratory hypersensitivity to trimellitic anhydride in Brown Norway rats: analysis of dose–response following topical induction and time course following repeated inhalation challenge
Toxicology
(2003)- et al.
Partial C-fiber ablation modulates diphenylmethane-4,4′-diisocyanate (MDI)-induced respiratory allergy in Brown-Norway rats
Toxicology
(2006) - et al.
Cytokine mRNA profiles for isocyanates with known and unknown potential to induce respiratory sensitization
Toxicology
(2005) - et al.
Asthma like biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder
The Journal of Allergy and Clinical Immunology
(2004)
Contact sensitivity and bioavailability of chlorocresol
Contact Dermatitis
Olive oil: suitability as a vehicle in the local lymph node assay
Contact Dermatitis
The impact of exposure variables on the induction of skin sensitization
Contact Dermatitis
Skin exposure to isocyanates: reasons for concern
Environmental Health Perspectives
Aetiological agents in occupational asthma
The European Respiratory Journal
Cytokines in asthma
Thorax
Food for thought: can immunological tolerance be induced to treat asthma?
American Journal of Respiratory Cell and Molecular Biology
Chemical Allergy: Considerations for the practical application of cytokine profiling
Toxicological Sciences
Methods for the identification of chemical respiratory allergens in rodents: comparison of cytokine profiling with induced changes in IgE
Journal of Applied Toxicology
Determination of isocyanates in working atmosphere by high performance liquid chromatography
Analytical Chemistry
Cited by (21)
How to assess respiratory sensitization of low molecular weight chemicals?
2020, International Journal of Hygiene and Environmental HealthCitation Excerpt :Investigations of dose-response relationships and/or threshold levels in respiratory allergy were reviewed by Arts et al. (2006) and later by Cochrane et al. (2015). However, although progress has been made (Botham et al., 1988; Griffiths-Johnson and Karol, 1991; Sarlo and Clark, 1992; Satoh et al., 1995; Hilton et al., 1996; Dearman and Kimber, 2001; Arts et al., 2008; Pauluhn, 2008; Lalko et al., 2011), none of the respiratory sensitization tests has yet resulted in a standard approach that can be used with confidence for the identification of respiratory sensitizers and as such has been included in an official OECD guideline. Besides the earlier mentioned uncertainty regarding the immunological mechanism involved, other reasons may be lack of time, resources, the need to set up a validation round with other labs, and thus costs, and the need to operate an inhalation facility.
Azodicarbonamide (ADCA): A reconsideration of classification as a respiratory sensitiser
2017, Regulatory Toxicology and PharmacologyBehaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation
2017, Regulatory Toxicology and PharmacologyCitation Excerpt :That does not imply a complete lack of progress, however. In fact, a variety of strategies (based on the use of mice, rats and guinea pigs models, in vitro approaches, and on the identification of structural alerts) have been considered (Botham et al., 1988; Griffiths-Johnson and Karol., 1991; Satoh et al., 1995; Hilton et al., 1996; Dearman and Kimber, 2001; Arts et al., 2008; Pauluhn, 2008; Lalko et al., 2011; Enoch et al., 2012), but none of these has gained traction within the scientific community as a preferred method, and none has been viewed as being of sufficient merit to warrant progression to a formal validation process. To a large extent the failure to identify an agreed method for the identification of chemical respiratory allergens is due to uncertainty about the mechanisms through which sensitisation of the respiratory tract to chemicals is acquired.
Development of a respiratory sensitization/elicitation protocol of toluene diisocyanate (TDI) in Brown Norway rats to derive an elicitation-based occupational exposure level
2014, ToxicologyCitation Excerpt :As explained by Raulf-Heimsoth et al. (2013), the differences (neutrophilic vs. eosinophilic airway inflammation) may depend on multiple methodological factors, the severity of response and the associated kinetics of cell influx into the fluids lining the airways. In this animal model it was shown that BAL-PMN was the most salient endpoint characterizing both MDI-aerosol induced asthma (Pauluhn, 2008a,b) and TDI-vapor-induced asthma. Systemic sensitization does not necessarily mean that these reactive isocyanates as such gain access to the systemic circulation suggesting putative bioavailability.
Micronuclei, hemoglobin adducts and respiratory tract irritation in mice after inhalation of toluene diisocyanate (TDI) and 4,4′-methylenediphenyl diisocyanate (MDI)
2011, Mutation Research - Genetic Toxicology and Environmental MutagenesisMultiple challenges in a mouse model of chemical-induced asthma lead to tolerance: Ventilatory and inflammatory responses are blunted, immunologic humoral responses are not
2009, ToxicologyCitation Excerpt :This rapid decrease of the lung inflammation occurred in parallel with the decreased airway hyper-reactivity in the TDI-treated mice. Overall, this decrease in response was unexpected, since in literature several multiple exposure protocols are described which yield better results than single exposure assays (Ban et al., 2006; Matheson et al., 2005b; Pauluhn, 2008a,b). Several valid explanations can be found in order these apparent inconsistencies.